Drug application
TRAVASE (SUTILAINS)
Drugs@FDA NDA 012828 · ABBOTT
Key facts
| Drug name | TRAVASE |
|---|---|
| Active ingredients | SUTILAINS |
| Application type | NDA |
| Application number | 012828 |
| Company | ABBOTT |
| Dosage forms | OINTMENT, TOPICAL |
| Strength | 82,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Jun 12, 1969 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.